Medication info
Hukra 375 mg Tablets (Amoxicillin and Clavulanate Potassium (2:1))

Hukra 375 mg Tablets (Amoxicillin and Clavulanate Potassium (2:1))

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›250mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
Huons Meditech Co., Ltd.
Appearance
White or nearly white oval film-coated tablets
Packaging
100 tablets (10 tablets/PTPX10)
Approval status
Active

MFDS item code 201803805 · Approved 2018.09.27 · Insurance code 670402140

Summary

Main use
Treatment of respiratory and ear, nose, and throat infections, genitourinary infections, and skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
The dosage of this medicine should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the beginning of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the beginning of a meal. Adults: Administer orally 250 mg/125 mg of amoxicillin/clavulanate potassium per dose 3 times daily, every 8 hours. The dose may be increased to 500 mg/125 mg of amoxicillin/clavulanate potassium per dose for severe infections and respiratory tract infections. In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is necessary in patients with creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min: Administer 250mg/125mg or 500mg/125mg of amoxicillin/clavulanate potassium per dose every 12 hours. 10 mL/min or less: Administer 250mg/125mg or 500mg/125mg of amoxicillin/clavulanate potassium per dose every 24 hours. Hemodialysis: Administer 250mg/125mg or 500mg/125mg of amoxicillin/clavulanate potassium per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanate decrease)
Child dose
Children aged 12 years or older or weighing 40 kg or more: Administer orally 3 times daily, every 8 hours, at a dose of 250 mg/125 mg of amoxicillin/potassium clavulanate; for severe infections and respiratory infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
Huons Meditech Co., Ltd.

Efficacy & effects

Treatment of respiratory and ear, nose, and throat infections, genitourinary infections, and skin, bone, and dental infections

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infections
View approved original text

This medication is used to treat infections caused by various bacteria. It is effective against respiratory infections such as acute and chronic bronchitis, lobar pneumonia and bronchopneumonia, empyema and lung abscess, tonsillitis, sinusitis, and otitis media. It is also used for urinary tract infections such as cystitis, urethritis, pyelonephritis, pelvic infections, and gonorrhea. It is helpful in treating skin and soft tissue infections such as boils, abscesses, cellulitis, wound infections, as well as osteomyelitis and dental infections. This drug is reliable for the treatment of various bacterial infections, including those caused by beta-lactamase producing strains. Therefore, this medication is used to improve a wide range of bacterial infections.

How to take

Adult dose

The dosage of this medicine should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the beginning of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the beginning of a meal. Adults: Administer orally 250 mg/125 mg of amoxicillin/clavulanate potassium per dose 3 times daily, every 8 hours. The dose may be increased to 500 mg/125 mg of amoxicillin/clavulanate potassium per dose for severe infections and respiratory tract infections. In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is necessary in patients with creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min: Administer 250mg/125mg or 500mg/125mg of amoxicillin/clavulanate potassium per dose every 12 hours. 10 mL/min or less: Administer 250mg/125mg or 500mg/125mg of amoxicillin/clavulanate potassium per dose every 24 hours. Hemodialysis: Administer 250mg/125mg or 500mg/125mg of amoxicillin/clavulanate potassium per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanate decrease)

Child dose

Children aged 12 years or older or weighing 40 kg or more: Administer orally 3 times daily, every 8 hours, at a dose of 250 mg/125 mg of amoxicillin/potassium clavulanate; for severe infections and respiratory infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. Children: Reduce the dose in the same manner.

Precautions

This medication is a beta-lactam antibiotic and should not be administered to patients with a history of hypersensitivity to penicillins, particularly those with a history of anaphylaxis or severe skin reactions. It is also advisable to avoid this medication in patients with infectious mononucleosis or lymphocytic leukemia, as they are at a higher risk of developing rashes. Patients who have previously experienced jaundice or hepatic dysfunction due to this medication or penicillins should also avoid administration. Patients with compromised liver function or moderate to severe renal impairment should use this medication carefully, regulating the dose and interval. Patients with a history of allergies, those who have difficulty swallowing, the elderly, and those in poor general health should also take caution. This medication can cause gastrointestinal symptoms such as diarrhea, vomiting, and abdominal pain, and in rare cases, serious adverse effects like colitis or acute pancreatitis may occur. Should any unusual symptoms appear, discontinue the medication and consult a physician immediately. Reports of hepatic dysfunction symptoms have also been noted, particularly in elderly patients or males, so liver function tests are necessary with prolonged use. Furthermore, severe allergic reactions such as skin rashes, urticaria, anaphylactic shock may occur infrequently; therefore, discontinue the use of the drug should any unusual symptoms manifest. Changes in blood tests, such as leukopenia, thrombocytopenia, or hemolytic anemia, have been reported rarely; regular blood tests are recommended. Central nervous system symptoms such as rare headaches, seizures, and confusion may also occur, and attention to renal function is necessary. This drug may interact with other medications, particularly anticoagulants or when combined with specific antibiotics or anti-inflammatory drugs. It may reduce the effectiveness of oral contraceptives, requiring additional contraceptive methods if necessary. The safety of this medication is not established in the early stages of pregnancy or during pregnancy; thus, it should only be used if absolutely necessary. During breastfeeding, it may cause diarrhea or allergic reactions in infants, and administration should be discontinued if adverse symptoms arise. Use in children, especially those under 12 years old or weighing less than 40 kg, is not recommended. In the elderly, the risk of adverse effects is higher due to diminished physiological function; therefore, careful observation of dosage and intervals is necessary. Regular tests for liver function, kidney function, and blood tests are required during the course of medication. In case of overdose, seek medical attention immediately for appropriate treatment. Store in a tightly sealed container, avoiding moisture, and keep in a cool place between 1 and 25 degrees Celsius. This storage will help maintain the drug's efficacy over time.

Side effects

  • Diarrhea
  • pseudomembranous colitis
  • indigestion
  • stomatitis
  • gastritis
  • glossitis
  • black hairy tongue
  • nausea
  • vomiting
  • loss of appetite
Show 75 more
  • abdominal pain
  • abdominal bloating
  • constipation
  • colonic pain
  • hyperacidity
  • soft stools
  • dry mouth
  • acute pancreatitis
  • candidiasis
  • antibiotic-associated colitis
  • bloody stools
  • itching
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • vesicular exfoliative dermatitis
  • acute generalized pustular psoriasis
  • eosinophilia
  • angioedema
  • anaphylaxis
  • serum sickness
  • hypersensitivity vasculitis
  • bronchospasm
  • dyspnea
  • laryngeal edema
  • anaphylactic shock
  • leukopenia
  • thrombocytopenia
  • hemolytic anemia
  • anemia
  • thrombocytopenic purpura
  • eosinophilia
  • leukemia
  • agranulocytosis
  • lymphocytopenia
  • thrombocytosis
  • bone marrow suppression
  • prolonged bleeding time
  • prolonged prothrombin time
  • vaginal itching
  • vaginal burning
  • increased secretion
  • restlessness
  • anxiety
  • behavioral changes
  • confusion
  • drowsiness
  • insomnia
  • hyperactivity
  • dizziness
  • headache
  • seizures
  • antispasmodic
  • fever
  • altered consciousness
  • aseptic meningitis
  • acute renal failure
  • interstitial nephritis
  • hematuria
  • crystalluria
  • vitamin K deficiency symptoms
  • vitamin B group deficiency symptoms
  • linear IgA disease
  • taste disturbances
  • lethargy
  • dermatitis
  • oral edema
  • gastric pain
  • fluid and electrolyte imbalance
  • rash
  • hyperactivity
  • drowsiness
  • renal failure
  • interstitial cerebral seizures
  • hypersensitivity shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent moisture and kept in a cool place between 1 and 25 degrees Celsius. Storing it this way will help maintain the drug's effect for a longer period.

Appearance and packaging

Appearance

White or nearly white oval film-coated tablets

Package unit

100 tablets (10 tablets/PTPX10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.